Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
HCAT on Nasdaq
Kevin Lee Freeman - trading volume in the past year for Health Catalyst, Inc.
Holdings reported by Kevin Lee Freeman for Health Catalyst, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
237K |
$2.12M |
$8.94 |
Dec 2, 2024 |
Direct |
|
|
Transactions reported by Kevin Lee Freeman for Health Catalyst, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.